STOCK TITAN

Tandem Diabetes Care CFO converts vested stock awards

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Tandem Diabetes Care Inc. (TNDM) Executive Vice President and Chief Financial Officer Leigh Vosseller reported vesting of 1,495 and 2,624 restricted stock units into common shares on November 15, 2026. The issuer withheld 537 and 942 shares to satisfy tax withholding requirements upon vesting; the footnote states that no shares were sold. A separate indirect holding entry lists 25,580 common shares in the Leigh A. Vosseller Trust, of which Vosseller is trustee.

Insider Vosseller Leigh
Role EVP & CHIEF FINANCIAL OFFICER
Type Security Shares Price Value
Exercise Restricted Stock Unit F3, F4, F5 1,495 $0.00 $0.00
Exercise Restricted Stock Unit F6, F4, F7 2,624 $0.00 $0.00
Exercise Common Stock 1,495 $0.00 $0.00
Tax Withholding Common Stock F1 537 $20.07 $11K
Exercise Common Stock 2,624 $0.00 $0.00
Tax Withholding Common Stock F1 942 $20.07 $19K
Holding Common Stock F2 -- -- --
Holdings After Transaction: Restricted Stock Unit — 18,735 units (Direct); Common Stock — 54,680 shares (Direct); Common Stock — 25,580 shares (Indirect, Leigh A. Vosseller Trust)
Holdings Before and After: Restricted Stock Unit, 22,854 to 18,735 units (Direct); Common Stock, 52,040 to 54,680 shares (Direct)
Footnotes (7)
  1. F1. Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.
  2. F2. The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee.
  3. F3. Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
  4. F4. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
  5. F5. One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
  6. F6. Awarded on May 30, 2025 pursuant to the 2023 Plan.
  7. F7. One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
RSUs converted 1,495 RSUs Reported on November 15, 2026; converted into common shares.
RSUs converted 2,624 RSUs Reported on November 15, 2026; converted into common shares.
Shares withheld for tax withholding 537 shares Reported on November 15, 2026.
Shares withheld for tax withholding 942 shares Reported on November 15, 2026.
Reported price per share $20.07 per share Listed for both withholding entries on November 15, 2026.
Indirect trust holding 25,580 common shares Listed for the Leigh A. Vosseller Trust on November 15, 2026; Vosseller is trustee.
Restricted Stock Unit financial
"vesting of restricted stock units (RSUs)"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
2023 Long-Term Incentive Plan financial
"pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan"
tax withholding requirements financial
"to satisfy tax withholding requirements upon the vesting of restricted stock units"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did TNDM CFO Leigh Vosseller vest?

Leigh Vosseller reported 1,495 and 2,624 restricted stock units converting into common shares on November 15, 2026.

How many shares were withheld from Leigh Vosseller's TNDM RSU vesting?

The issuer withheld 537 and 942 shares to satisfy tax withholding requirements upon RSU vesting. The footnote states that no shares were sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Vosseller Leigh

(Last)(First)(Middle)
12400 HIGH BLUFF DRIVE

(Street)
SAN DIEGO CALIFORNIA 92130

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TANDEM DIABETES CARE INC [ TNDM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & CHIEF FINANCIAL OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/15/2026M1,495A$053,535D
Common Stock11/15/2026F(1)537D$20.0752,998D
Common Stock11/15/2026M2,624A$055,622D
Common Stock11/15/2026F(1)942D$20.0754,680D
Common Stock25,580ILeigh A. Vosseller Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(3)(4)11/15/2026M1,495 (5) (5)Common Stock1,495$02,991D
Restricted Stock Unit(6)(4)11/15/2026M2,624 (7) (7)Common Stock2,624$015,744D
Explanation of Responses:
1. Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.
2. The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee.
3. Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
4. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
5. One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
6. Awarded on May 30, 2025 pursuant to the 2023 Plan.
7. One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
Remarks:
/s/ Jerilyn Laskie, Attorney-in-Fact for Leigh A. Vosseller11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading